Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Ardelyx Operating Expenses 2013-2025 | ARDX

Ardelyx operating expenses from 2013 to 2025. Operating expenses can be defined as the sum of all operating expenses for the given industry.
  
Ardelyx Annual Operating Expenses
(Millions of US $)
2024 $362
2023 $188
2022 $116
2021 $164
2020 $98
2019 $97
2018 $94
2017 $107
2016 $113
2015 $53
2014 $33
2013 $32
2012 $14
Ardelyx Quarterly Operating Expenses
(Millions of US $)
2025-06-30 $112
2025-03-31 $110
2024-12-31 $108
2024-09-30 $96
2024-06-30 $87
2024-03-31 $71
2023-12-31 $62
2023-09-30 $49
2023-06-30 $39
2023-03-31 $37
2022-12-31 $32
2022-09-30 $27
2022-06-30 $29
2022-03-31 $28
2021-12-31 $36
2021-09-30 $43
2021-06-30 $46
2021-03-31 $39
2020-12-31 $29
2020-09-30 $20
2020-06-30 $26
2020-03-31 $23
2019-12-31 $21
2019-09-30 $25
2019-06-30 $25
2019-03-31 $25
2018-12-31 $27
2018-09-30 $24
2018-06-30 $22
2018-03-31 $20
2017-12-31 $31
2017-09-30 $21
2017-06-30 $26
2017-03-31 $28
2016-12-31 $31
2016-09-30 $29
2016-06-30 $29
2016-03-31 $24
2015-12-31 $17
2015-09-30 $18
2015-06-30 $9
2015-03-31 $9
2014-12-31 $10
2014-09-30 $8
2014-06-30 $6
2014-03-31 $9
2013-12-31 $9
2013-09-30 $7
2013-06-30 $8
2013-03-31 $7
2012-12-31
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $1.460B $0.334B
Ardelyx, Inc. is a clinical-stage biopharmaceutical company. It discovers, develops and commercializes small molecule therapeutics that work in the gastrointestinal tract to treat cardio-renal, GI and metabolic diseases. The Company's lead product candidate is Tenapanor which is in three ongoing Phase II clinical trials for the treatment of patients with ESRD-HD and chronic kidney disease, as well as for constipation-predominant irritable bowel syndrome. Ardelyx, Inc. is headquartered in Fremont, California.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $68.778B 24.95
Chugai Pharmaceutical (CHGCY) Japan $68.684B 26.42
Takeda Pharmaceutical (TAK) Japan $47.952B 9.79
Daiichi Sankyo, - (DSNKY) Japan $47.757B 24.48
BeOne Medicines - (ONC) Switzerland $33.826B 0.00
Sandoz Group AG (SDZNY) Switzerland $27.575B 0.00
Summit Therapeutics (SMMT) United States $19.515B 0.00
Merck (MKKGY) Germany $16.543B 10.76
Shionogi (SGIOY) Japan $14.700B 14.73
United Therapeutics (UTHR) United States $13.775B 11.92
Neurocrine Biosciences (NBIX) United States $13.289B 39.64
IPSEN (IPSEY) France $11.429B 0.00
Orion OYJ (ORINY) Finland $11.336B 27.32
Eisai (ESAIY) $9.228B 10.41
Madrigal Pharmaceuticals (MDGL) United States $9.153B 0.00
Corcept Therapeutics (CORT) United States $7.252B 60.90
Grifols, S.A (GRFS) Spain $6.752B 0.00
Ionis Pharmaceuticals (IONS) United States $6.666B 0.00
Stevanato Group S.p.A (STVN) Italy $6.660B 39.27
Ono Pharmaceutical (OPHLF) Japan $5.740B 19.71
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.436B 0.00
Soleno Therapeutics (SLNO) United States $3.535B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.915B 13.85
Crinetics Pharmaceuticals (CRNX) United States $2.834B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $2.782B 0.00
Hypermarcas (HYPMY) Brazil $2.755B 20.71
Catalyst Pharmaceuticals (CPRX) United States $2.524B 8.45
Procaps Group, S.A (PROCF) Luxembourg $2.419B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $2.277B 0.00
Ocular Therapeutix (OCUL) United States $2.065B 0.00
Dyne Therapeutics (DYN) United States $1.849B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.761B 0.00
Guardian Pharmacy Services (GRDN) United States $1.661B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.597B 23.79
Avadel Pharmaceuticals (AVDL) Ireland $1.438B 0.00
Harrow (HROW) United States $1.382B 0.00
ARS Pharmaceuticals (SPRY) United States $1.335B 0.00
Evotec AG (EVO) Germany $1.268B 0.00
Xeris Biopharma Holdings (XERS) United States $1.255B 0.00
Collegium Pharmaceutical (COLL) United States $1.221B 6.67
Enliven Therapeutics (ELVN) United States $1.181B 0.00
Cronos Group (CRON) Canada $0.992B 0.00
Akebia Therapeutics (AKBA) United States $0.803B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.758B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.731B 7.53
Theravance Biopharma (TBPH) United States $0.695B 57.48
ProKidney (PROK) United States $0.692B 0.00
KalVista Pharmaceuticals (KALV) United States $0.654B 0.00
Siga Technologies (SIGA) United States $0.623B 7.70
Bioventus (BVS) United States $0.615B 14.88
Relay Therapeutics (RLAY) United States $0.605B 0.00
Elite Pharmaceuticals (ELTP) United States $0.594B 0.00
Organogenesis (ORGO) United States $0.592B 0.00
Tourmaline Bio (TRML) United States $0.583B 0.00
USANA Health Sciences (USNA) United States $0.581B 11.91
Xencor (XNCR) United States $0.571B 0.00
Oruka Therapeutics (ORKA) United States $0.543B 0.00
Savara (SVRA) United States $0.543B 0.00
Zevra Therapeutics (ZVRA) United States $0.525B 0.00
Nektar Therapeutics (NKTR) United States $0.516B 0.00
Nanobiotix S.A (NBTX) France $0.472B 0.00
Esperion Therapeutics (ESPR) United States $0.433B 0.00
Aquestive Therapeutics (AQST) United States $0.385B 0.00
Aldeyra Therapeutics (ALDX) United States $0.346B 0.00
4D Molecular Therapeutics (FDMT) United States $0.315B 0.00
Larimar Therapeutics (LRMR) United States $0.308B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.303B 0.00
Altimmune (ALT) United States $0.299B 0.00
AleAnna (ANNA) United States $0.294B 0.00
Nature's Sunshine Products (NATR) United States $0.293B 19.07
Galectin Therapeutics (GALT) United States $0.256B 0.00
Lexeo Therapeutics (LXEO) United States $0.252B 0.00
Heron Therapeutics (HRTX) United States $0.212B 0.00
Lyell Immunopharma (LYEL) United States $0.211B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.206B 31.75
OmniAb (OABI) United States $0.200B 0.00
Aclaris Therapeutics (ACRS) United States $0.195B 0.00
Korro Bio (KRRO) United States $0.188B 0.00
MediWound (MDWD) Israel $0.186B 0.00
Journey Medical (DERM) United States $0.180B 0.00
Innate Pharma SA (IPHYF) France $0.173B 0.00
China SXT Pharmaceuticals (SXTC) China $0.172B 0.00
Achieve Life Sciences (ACHV) Canada $0.169B 0.00
MEI Pharma (MEIP) United States $0.162B 0.00
Profound Medical (PROF) Canada $0.140B 0.00
Wellgistics Health (WGRX) United States $0.138B 0.00
Inhibikase Therapeutics (IKT) United States $0.131B 0.00
Avita Medical (RCEL) United States $0.124B 0.00
Avalo Therapeutics (AVTX) United States $0.124B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.121B 0.00
Protara Therapeutics (TARA) United States $0.118B 0.00
Cassava Sciences (SAVA) United States $0.104B 0.00
Surrozen (SRZN) United States $0.099B 0.00
Champions Oncology (CSBR) United States $0.097B 22.06
Dominari Holdings (DOMH) United States $0.096B 0.00
Cardiol Therapeutics (CRDL) Canada $0.095B 0.00
Liminatus Pharma (LIMN) United States $0.088B 0.00
BioNxt Solutions (BNXTF) Canada $0.087B 0.00
Pyxis Oncology (PYXS) United States $0.086B 0.00
VAXART, INC (VXRT) United States $0.081B 0.00
Context Therapeutics (CNTX) United States $0.078B 0.00
Arch Biopartners (ACHFF) Canada $0.077B 0.00
Unicycive Therapeutics (UNCY) United States $0.076B 0.00
Assertio Holdings (ASRT) United States $0.076B 0.00
PMV Pharmaceuticals (PMVP) United States $0.075B 0.00
Vivani Medical (VANI) United States $0.073B 0.00
Prelude Therapeutics (PRLD) United States $0.072B 0.00
Nutriband (NTRB) United States $0.071B 0.00
Metagenomi (MGX) United States $0.071B 0.00
Gain Therapeutics (GANX) United States $0.066B 0.00
DURECT (DRRX) United States $0.060B 0.00
Inotiv (NOTV) United States $0.060B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.057B 0.00
PolyPid (PYPD) Israel $0.055B 0.00
Karyopharm Therapeutics (KPTI) United States $0.055B 0.00
NRx Pharmaceuticals (NRXP) United States $0.053B 0.00
Rafael Holdings (RFL) United States $0.052B 0.00
Fractyl Health (GUTS) United States $0.050B 0.00
Jupiter Neurosciences (JUNS) United States $0.050B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.049B 29.64
Plus Therapeutics (PSTV) United States $0.048B 0.00
Telomir Pharmaceuticals (TELO) United States $0.047B 0.00
Tempest Therapeutics (TPST) United States $0.047B 0.00
Klotho Neurosciences (KLTO) United States $0.046B 0.00
Century Therapeutics (IPSC) United States $0.044B 0.00
FibroGen (FGEN) United States $0.043B 0.00
Acrivon Therapeutics (ACRV) United States $0.042B 0.00
ElectroCore (ECOR) United States $0.040B 0.00
ESSA Pharma (EPIX) Canada $0.037B 0.00
Mural Oncology (MURA) Ireland $0.036B 0.00
SCYNEXIS (SCYX) United States $0.035B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.035B 0.00
Vivos Therapeutics (VVOS) United States $0.035B 0.00
Iterum Therapeutics (ITRM) Ireland $0.032B 0.00
CASI Pharmaceuticals (CASI) China $0.030B 0.00
Enlivex Therapeutics (ENLV) Israel $0.026B 0.00
Cosmos Health (COSM) United States $0.025B 0.00
Natural Alternatives (NAII) United States $0.024B 0.00
Incannex Healthcare (IXHL) Australia $0.022B 0.00
Citius Pharmaceuticals (CTXR) United States $0.021B 0.00
Relmada Therapeutics (RLMD) United States $0.021B 0.00
Ainos (AIMD) United States $0.018B 0.00
Mannatech (MTEX) United States $0.018B 0.00
Mangoceuticals (MGRX) United States $0.018B 0.00
Scienture Holdings (SCNX) United States $0.017B 0.00
BioLineRx (BLRX) Israel $0.016B 0.00
Lipocine (LPCN) United States $0.016B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.016B 0.00
ProPhase Labs (PRPH) United States $0.014B 0.00
TherapeuticsMD (TXMD) United States $0.013B 0.00
Aptorum Group (APM) United Kingdom $0.012B 0.00
BioVie (BIVI) United States $0.012B 0.00
Talphera (TLPH) United States $0.012B 0.00
Phio Pharmaceuticals (PHIO) United States $0.011B 0.00
Lyra Therapeutics (LYRA) United States $0.011B 0.00
Heatwurx (PCSA) United States $0.011B 0.00
Ernexa Therapeutics (ERNA) United States $0.011B 0.00
Traws Pharma (TRAW) United States $0.010B 0.02
CERo Therapeutics Holdings (CERO) United States $0.009B 0.00
Carisma Therapeutics (CARM) United States $0.009B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.009B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.009B 0.00
Biomerica (BMRA) United States $0.009B 0.00
Addex Therapeutics (ADXN) Switzerland $0.008B 0.00
VYNE Therapeutics (VYNE) United States $0.008B 0.00
TransCode Therapeutics (RNAZ) United States $0.008B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.008B 0.00
Indaptus Therapeutics (INDP) United States $0.008B 0.00
Vyome Holdings (HIND) United States $0.008B 0.00
Nuvilex (PMCB) United States $0.007B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.007B 0.00
CDT Equity (CDT) United States $0.005B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.005B 0.00
Aditxt (ADTX) United States $0.005B 0.00
InMed Pharmaceuticals (INM) Canada $0.004B 0.00
Xenetic Biosciences (XBIO) United States $0.004B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
Alaunos Therapeutics (TCRT) United States $0.004B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
Jaguar Animal Health (JAGX) United States $0.004B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.004B 0.00
PainReform (PRFX) Israel $0.004B 0.00
Qualigen Therapeutics (QLGN) United States $0.003B 0.00
Redhill Biopharma (RDHL) Israel $0.003B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.003B 0.00
SHINECO (SISI) China $0.003B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
SciSparc (SPRC) Israel $0.002B 0.00
Universe Pharmaceuticals INC (UPC) China $0.002B 0.00
TNF Pharmaceuticals (TNFA) United States $0.001B 0.00
Indivior (INDV) United States $0.000B 13.49
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Minerva Neurosciences (NERV) United States $0.000B 1.61
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00